Inhibrx Biosciences Inc (INBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 11,540 | N/A | N/A |
| Receivables | 438 | N/A | N/A |
| TOTAL | $15,561 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 3,230 | N/A | N/A |
| Other Non-Current Assets | 7,698 | 0 | 0 |
| TOTAL | $10,928 | $N/A | $N/A |
| Total Assets | $26,489 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 3,563 | N/A | N/A |
| Accounts payable and accrued liabilities | 3,115 | 0 | 0 |
| Accrued Expenses | 4,832 | N/A | N/A |
| Other current liabilities | 16 | N/A | N/A |
| TOTAL | $20,570 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Deferred Revenues | 7,939 | N/A | N/A |
| Other Non-Current Liabilities | 91,790 | 0 | 0 |
| TOTAL | $99,488 | $N/A | $N/A |
| Total Liabilities | $120,058 | $N/A | $N/A |
| Shareholders' Equity | |||
| Common Shares | 2 | N/A | N/A |
| Retained earnings | -69,255 | N/A | N/A |
| TOTAL | $-93,569 | $N/A | $N/A |
| Total Liabilities And Equity | $26,489 | $0 | $0 |